GRAIL Revenue and Competitors
Estimated Revenue & Valuation
- GRAIL's estimated annual revenue is currently $423.6M per year.
- GRAIL received $300.0M in venture funding in May 2018.
- GRAIL's estimated revenue per employee is $248,000
- GRAIL's total funding is $2B.
- GRAIL's current valuation is $2.5B.
Employee Data
- GRAIL has 1708 Employees.
- GRAIL grew their employee count by 5% last year.
GRAIL's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Staff | Reveal Email/Phone |
2 | SVP, Chief Scientific Officer | Reveal Email/Phone |
3 | Distinguished Scientist, VP Corporate Affairs | Reveal Email/Phone |
4 | Chief Staff, Enterprise Commercial | Reveal Email/Phone |
5 | Chief Medical Officer | Reveal Email/Phone |
6 | Chief Staff | Reveal Email/Phone |
7 | VP, Strategic Partnerships and Initiatives | Reveal Email/Phone |
8 | VP, Business Development and Alliance Management | Reveal Email/Phone |
9 | VP Bioinformatics and Data Science | Reveal Email/Phone |
10 | VP, NHS Implementation & External Affairs | Reveal Email/Phone |
GRAIL Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $20.5M | 132 | 8% | $1.4B | N/A |
#2 | $141.7M | 653 | 11% | $1.35B | N/A |
What Is GRAIL?
GRAIL is a life sciences company whose mission is to detect cancer early, when it can be cured. GRAIL is using the power of high-intensity sequencing, population-scale clinical trials, and state of the art Computer Science and Data Science to enhance the scientific understanding of cancer biology and develop blood tests for early-stage cancer detection. The company has secured over $1B in venture funding led by ARCH Venture Partners and including Amazon, Bezos Expeditions, Bill Gates, Bristol-Myers Squibb, Celgene, GV, Illumina, Johnson & Johnson Innovation, Merck, McKesson Ventures, Sutter Hill Ventures, Tencent, Varian Medical Systems, and other financial partners. If you're ready to join a mission with meaning, bring your passion to GRAIL. Together we will make history in the fight against cancer.
keywords:Biotechnology, Life Sciences, Healthcare, Diagnostics, Medical Technologies, Medical Device
$2B
Total Funding
1708
Number of Employees
$423.6M
Revenue (est)
5%
Employee Growth %
$2.5B
Valuation
N/A
Accelerator
GRAIL News
Ask anyone who's into muscle cars which car of the 1960s and 70s best represents that era, and the Dodge Ch...
NEWTOWN BOROUGH Run away! Run away! To the historic Newtown Theatre on Friday, May 20 when the theatre brings Monty Python and the Holy...
A raft of multicancer blood tests are under development that promise early detection. Our verdict on Grail's Galleri: An exciting innovation...
Earlier this year, the Federal Trade Commission’s (FTC) posed a roadblock in the path of sequencing giant Illumina’s $7.1 billion proposed acquisition of Grail, a healthcare company focusing on early cancer detection, and importantly, a 2016 spin-out from the former. Right now, the European Comm ...
Biotech has become one of the hottest areas of venture investment in recent years, as progress in machine learning, genetics, medical devices and biology fuse together into new products for the gargantuan health industry. Case in point: Grail, which began in 2016 as a spinoff from genetic seque ...
Other Companies in Menlo Park
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $291.6M | 1999 | 7% | $19.8M |
#2 | $407.8M | 2009 | 2% | N/A |
#3 | $707.7M | 2466 | 19% | N/A |
#4 | $1770M | 3127 | 3% | $5.6B |
#5 | $520.1M | 3642 | 20% | N/A |
GRAIL Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2017-03-02 | $900.0M | B | Arch Venture Partners | Article |
| 2017-11-23 | $1211.7M | B | ARCH Venture Partners | Article |
| 2018-05-22 | $300.0M | C | Ally Bridge Group | Article |